Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 21 clinical trials
Double-Blind, Randomized, Parallel-Group Study With Quetiapine Extended Release as Comparator to Evaluate the Efficacy and Safety of Seltorexant 20 mg as Adjunctive Therapy to Antidepressants in Adult and Elderly Patients With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant Therapy

participants with major depressive disorder with insomnia symptoms (MDDIS) who have had an inadequate response to current antidepressant therapy with a selective serotonin reuptake inhibitor (SSRI) or

depression
vortioxetine
quetiapine
venlafaxine
major depressive disorder
  • 1402 views
  • 28 Oct, 2022
  • 129 locations
  • 0 views
  • 14 Oct, 2022
  • 8 locations
  • 88 views
  • 24 Oct, 2022
  • 94 locations
Pharmaco(Epi)Genetic Study of Obsessive-Compulsive Disorder

The purpose of this study is to determine whether pharmaco(epi)genetic study predict selective serotonin reuptake inhibitor (SSRI) responsiveness in advance before the appearance of the drug

psychiatric disorder
serotonin reuptake inhibitors
fluoxetine
  • 23 views
  • 15 May, 2022
  • 1 location
Escitalopram and Language Intervention for Subacute Aphasia (ELISA)

In this project, the investigators will investigate the effects of a selective serotonin reuptake inhibitor (SSRI), escitalopram, on augmenting language therapy effectiveness, as measured by

  • 0 views
  • 11 May, 2022
  • 3 locations
  • 0 views
  • 19 Oct, 2022
  • 2 locations
Open-label Long-Term Extension Study for Participants With Treatment-Resistant Major Depressive Disorder Who Are Continuing Esketamine Nasal Spray Treatment From Study 54135419TRD3013 (ESCAPE-LTE)

The primary purpose of this study is to assess the long-term safety and tolerability of esketamine nasal spray in combination with a selective serotonin reuptake inhibitor/serotonin

  • 4 views
  • 22 Oct, 2022
  • 9 locations
Predicting SSRI Efficacy in Veterans With PTSD (SSRI)

positive response to selective serotonin reuptake inhibitor (SSRI) medications. Participants will be recruited over approximately 3.25 years, until at least 94 participants complete the 17 week study.

depression
selective serotonin reuptake inhibitors
sertraline
  • 2 views
  • 14 Apr, 2022
  • 1 location
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-arm Trial to Assess the Efficacy, Safety, and Tolerability of Centanafadine Extended-release Capsules as Monotherapy or as Adjunct to SSRI in Adult Subjects With Major Depressive Disorder (JUNIPER)

their current major depressive episode. The trial will evaluate the efficacy and safety of centanafadine QD XR capsules as monotherapy or as adjunct to the selective serotonin reuptake inhibitor

  • 0 views
  • 14 Oct, 2022
An Adaptive Algorithm-Based Approach to Treatment for Adolescent Depression

selective serotonin reuptake inhibitor (SSRI) or more intensive IPT-A (delivered twice per week). Research assessments will be administered at baseline and at weeks 4, 8, 12, 16, and 36.

depression
psychotherapy
major depressive disorder
depressive symptoms
depressive disorder
  • 109 views
  • 06 May, 2022
  • 1 location